Chairman
MBX Biosciences, Inc. (MBX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Steven Hoerter is recorded as CEO and Chairman at MBX Biosciences, Inc. (MBX). MBX Biosciences, Inc. reported in an 8-K filed July 13, 2026 that Steven Hoerter was appointed President and Chief Executive Officer and principal executive officer, effective July 13, 2026. MBX Biosciences, Inc. reported in an 8-K filed November 6, 2025 that Steven Hoerter was appointed executive chairperson of the Board, effective November 6, 2025. Steven Hoerter has spoken on 1 investor event across 1 company, most recently for MBX Biosciences, Inc. on September 16, 2026.
“On July 9, 2026, the Board appointed Steven Hoerter, the Company's current executive Chairman of the Board, as President and Chief Executive Officer and principal executive officer of the Company, effective as of July 13, 2026 (the "Effective Date").”
“On November 3, 2025, Steven Hoerter, a current member of the Board, was appointed to serve as executive chairperson of the Board, effective as of November 6, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-07-13–present
2025-11-06–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Chairman
2025-11-06–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
